MedPath

The comparison of alfa glucosidase inhibitor or glinide based DPP-4 inhibitor combination therapy in drug-naive type 2 diabetic patients.

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000016011
Lead Sponsor
ippon Medical School Chiba Hokusoh Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

An antidiabetic is given. The patient have serious liver dysfunction. The patient have moderate or severe renal dysfunction. The patient have a malignant tumor. The patient become pregnant or may become pregnant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycemic control improvement effect and hypoglycaemic attack frequency
Secondary Outcome Measures
NameTimeMethod
postprandial serum glucose and lipids improvement effect, change of the serum insulin and incretin level
© Copyright 2025. All Rights Reserved by MedPath